Medical Developments International | MVP - Current Liabilities


Medical Developments International reported AUD5.56M in Current Liabilities for its fiscal semester ending in December of 2025.





Current Liabilities Change Date
Akebia Therapeutics USD 162.35M 1.48M Sep/2026
Alaunos Therapeutics USD 864K 269K Jun/2026
Avita Medical AUD 68.71M 6.04M Jun/2026
Clinuvel Pharmaceuticals AUD 17.85M 9.36M Dec/2025
Dianthus Therapeutics USD 28.51M 5.87M Sep/2026
Genetic Signatures AUD 4.78M 680K Dec/2025
Ionis Pharmaceuticals USD 435.29M 119.65M Sep/2026
Medical Developments International AUD 5.56M 2.26M Dec/2025
Neuren Pharmaceuticals AUD 4.34M 3.58M Dec/2025
Organon & Co USD 2.65B 36M Sep/2026
PYC Therapeutics AUD 11.01M 1.31M Dec/2025
Starpharma Holdings AUD 4.61M 614K Dec/2025
Tectonic Therapeutic USD 10.37M 2.59M Jun/2026
Telix Pharmaceuticals AUD 242.34M 10.72M Jun/2026
Viatris USD 6.64B 290.7M Sep/2026
Xeris Pharmaceuticals USD 134.48M 55.09M Sep/2026